<TABLE> <S> <C>

<ARTICLE>                    5
<LEGEND>
                             THIS   SCHEDULE    CONTAINS    SUMMARY    FINANCIAL
                             INFORMATION     EXTRACTED    FROM    THE    MEDISYS
                             TECHNOLOGIES,  INC.  FINANCIAL  STATEMENTS  FOR THE
                             PERIOD ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS
                             ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                 1

<S>                                                    <C>
<PERIOD-TYPE>                                          3-MOS
<FISCAL-YEAR-END>                                                     DEC-31-2000
<PERIOD-START>                                                        JAN-01-2000
<PERIOD-END>                                                          MAR-31-2000
<CASH>                                                                  1,315,550
<SECURITIES>                                                                    0
<RECEIVABLES>                                                                 340
<ALLOWANCES>                                                                    0
<INVENTORY>                                                                 7,729
<CURRENT-ASSETS>                                                        1,347,447
<PP&E>                                                                     20,112
<DEPRECIATION>                                                                  0
<TOTAL-ASSETS>                                                          1,870,228
<CURRENT-LIABILITIES>                                                   1,938,043
<BONDS>                                                                 1,000,000
                                                           0
                                                                     0
<COMMON>                                                                   29,502
<OTHER-SE>                                                             15,825,362
<TOTAL-LIABILITY-AND-EQUITY>                                            1,870,228
<SALES>                                                                       623
<TOTAL-REVENUES>                                                              623
<CGS>                                                                         679
<TOTAL-COSTS>                                                           3,012,563
<OTHER-EXPENSES>                                                                0
<LOSS-PROVISION>                                                                0
<INTEREST-EXPENSE>                                                        162,000
<INCOME-PRETAX>                                                       (3,167,395)
<INCOME-TAX>                                                                    0
<INCOME-CONTINUING>                                                   (3,167,395)
<DISCONTINUED>                                                        (1,379,954)
<EXTRAORDINARY>                                                                 0
<CHANGES>                                                                       0
<NET-INCOME>                                                          (4,547,349)
<EPS-BASIC>                                                               (.09)
<EPS-DILUTED>                                                               (.09)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission